UPDATED May 16, 2022
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
X2SSinopharm Group | €2.22 | 6.6% | -18.5% | €56.7b | €2.87 | PS6.3x | E9.5% | 4.8% | ||
UK2Shandong Weigao Group Medical Polymer | €0.91 | 1.1% | -51.5% | €35.9b | €1.42 | PS13.8x | E14.9% | 2.1% | ||
X2S1Sinopharm Group | €10.60 | 5.0% | -20.0% | €56.7b | €13.69 | PS6.3x | E9.5% | 4.8% | ||
6SNNakanishi | €15.50 | 3.3% | -10.4% | €178.5b | €21.00 | PS17.6x | E5.5% | 1.9% | ||
A58Anthem | €465.55 | -0.5% | 43.8% | €117.3b | €531.48 | PS18.8x | E10.3% | 1.1% | ||
PD1Ansell | €66.00 | -3.7% | -34.0% | €3.3b | €73.30 | PS10.5x | E5.1% | 3.6% | ||
HTWNational HealthCare | €56.25 | 0% | -6.0% | €1.1b | n/a | PS7.7x | n/a | 3.2% | ||
PD1AAnsell | €17.50 | 1.6% | -33.4% | €3.3b | €19.44 | PS10.5x | E5.1% | 3.6% | ||
LABLaboratory Corporation of America Holdings | €236.30 | -0.7% | 4.8% | €22.7b | €298.90 | PS10.8x | E-1.6% | 1.2% |